Skip to content

RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial

A Randomized Comparison of RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01446263
Acronym
RADIAL-CABG
Enrollment
128
Registered
2011-10-05
Start date
2011-10-31
Completion date
2013-04-30
Last updated
2013-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Complication

Keywords

Radial access, Femoral access, Coronary angiography, Coronary artery bypass graft

Brief summary

Increased use of radial access for cardiac catheterization is being advocated because studies have showed lower arterial access related complication rates and higher patient satisfaction as compared to femoral access. However, little is known on patients with prior coronary artery bypass graft (CABG). The RADIAL CABG Trial is a randomized-controlled trial proposed to test the hypothesis that bypass graft angiography and intervention via radial access provides lower vascular complication rates, similar contrast and equipment utilization and higher patient satisfaction when compared with transfemoral approach.

Detailed description

This is a phase III, single-center, prospective, randomized trial that will compare resource utilization, clinical outcomes and patient satisfaction between radial and femoral access for patients with prior coronary artery bypass graft (CABG)surgery undergoing coronary and graft angiography and intervention. During clinically-indicated coronary angiography of patients with prior CABG, the amount resources used, radiation exposure to patients and operators, occurence of complications and patients satisfaction will be compared between the two treatment arms to determine whether compared to femoral approach radial access will result in: 1. similar contrast utilization (primary endpoint) 2. similar procedure time (secondary endpoint) 3. similar fluoroscopy time (secondary endpoint) 4. similar radiation exposure of the patient - measured as DAP \[dose area product\] and AK \[air kerma\] (secondary endpoint) 5. similar radiation exposure of the operators using portable radiation dose measuring devices (secondary endpoint) 6. similar number and types of catheters and guidewires used (secondary endpoint) 7. reduction in vascular access complications (secondary endpoint) 8. reduction in overall complications (vascular access complications,injury, bleeding, death, emergency coronary bypass surgery, stroke, acute myocardial infarction) (secondary endpoint) 9. higher patient satisfaction as measured by standardized survey 24-hours after the procedure (secondary endpoint)

Interventions

PROCEDURERadial access versus femoral access for coronary angiography and intervention

Radial access or femoral access for coronary angiography and intervention in patients with prior coronary artery bypass grafts

Sponsors

North Texas Veterans Healthcare System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Age \>18-years * Prior coronary artery bypass graft surgery * Referred for clinically-indicated coronary and graft angiography and/or intervention * Able to provide informed consent

Exclusion criteria

* Known pathologic Allen's test * Known difficulty that limits vascular access at the femoral or radial arteries * Age \> 90

Design outcomes

Primary

MeasureTime frame
Amount of contrast used24 hours

Secondary

MeasureTime frame
Total procedure time24 hours
Fluoroscopy time24 hours
Radiation exposure of the operators as measured as AK using portable radiation dose measuring devices24 hours
Performance of ascending aortic angiography to identify patent bypass grafts24 hours
Radiation exposure of the patients measured as DAP [dose area product] and AK [air kerma]24 hours
Vascular access complications (hematoma, aneurysm,pseudo-aneurysm, arterio-venous fistula formation, dissection, limb ischemia, bleeding)24 hours
Overall Complications (vascular access complications, injury, bleeding, death, emergency coronary bypass surgery, stroke, acute myocardial infarction)24 hours
Patient satisfaction, as measured by questionnaire administered 24 hours after the procedure24 hours
Number of catheters and wires used24 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026